Concepedia

Publication | Open Access

Outcome of Everolimus-Based Therapy in Hormone-Receptor-Positive Metastatic Breast Cancer Patients After Progression on Palbociclib

40

Citations

19

References

2020

Year

Abstract

Everolimus was associated with modest PFS and ORR in HR+ HER2-MBCs postprogression on palbociclib.

References

YearCitations

Page 1